Atagabalin
Atagabalin (PD-0200,390) is a drug developed by Pfizer and related to gabapentin, which similarly binds to the α2δ calcium channels (1 and 2). It was under development as a treatment for insomnia, but was discontinued following unsatisfactory trial results.
primaryTopic
Atagabalin
Atagabalin (PD-0200,390) is a drug developed by Pfizer and related to gabapentin, which similarly binds to the α2δ calcium channels (1 and 2). It was under development as a treatment for insomnia, but was discontinued following unsatisfactory trial results.
has abstract
Atagabalin (PD-0200,390) is a ...... unsatisfactory trial results.
@en
アタガバリン(Atagabalin)は、ファイザーが開発した ...... 1及び2)に結合する。不眠症の治療への応用が研究されている。
@ja
ATC prefix
CAS number
223445-75-8
FDA UNII code
JT7957Q2FB
IUPAC name
[(3S,4S)-1-(aminomethyl)-3,4-dimethylcyclopentyl]acetic acid
@en
PubChem
thumbnail
Wikipage page ID
32,135,974
Wikipage revision ID
724,118,330
ChEMBL
ChemSpiderID
molecular weight
1.85263e+2
smiles
StdInChIKey
IUVMAUQEZFTTFB-YUMQZZPRSA-N
Verifiedfields
verifiedrevid
477,351,069
Watchedfields
hypernym
comment
Atagabalin (PD-0200,390) is a ...... unsatisfactory trial results.
@en
アタガバリン(Atagabalin)は、ファイザーが開発した ...... 1及び2)に結合する。不眠症の治療への応用が研究されている。
@ja
label
Atagabalin
@en
アタガバリン
@ja
